# LXEO (Lexeo Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Lexeo Therapeutics, Inc. reported $243.9M in total assets and a net loss of $105.3M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/LXEO
- Markdown: https://convexityos.com/fundamentals/LXEO.md
- SEC CIK: 0001907108
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:42 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001907108&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$113.9M | Operating profit |
| Net Income | FY 2025 | -$105.3M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.19 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$98.96M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $194.8M | Total debt: $6.25M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $654K |
| Research & Development | $63.80M | $74.09M | $53.13M | $49.16M |
| Total Operating Expenses | $109.3M | $105.8M | $68.51M | $61.16M |
| **Operating Income** | -$109.3M | -$105.8M | -$68.51M | -$60.51M |
| **EBITDA** | -$109.0M | -$105.5M | -$68.24M | -$60.39M |
| Interest Income | $6.13M | $7.56M | $2.87M | $1.32M |
| Interest Expense | $95K | $137K | $205K | $91K |
| Income Before Tax | -$99.67M | -$98.44M | -$66.39M | -$59.28M |
| Income Tax Expense | $0 | $0 | -- | -- |
| **Net Income** | -$100.0M | -$98.33M | -$66.39M | -$59.28M |
| Basic EPS | -$1.86 | -$3.09 | -$12.40 | -$36.36 |
| **Diluted EPS** | -$1.86 | -$3.09 | -$12.40 | -$36.36 |
| Basic Shares Outstanding | 53.6M | 31.8M | 5.4M | 1.6M |
| Diluted Shares Outstanding | 53.6M | 31.8M | 5.4M | 1.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $34.50M | $19.03M | $15.70M | $16.21M | $15.70M | $14.72M | $17.17M | $18.37M |
| Total Operating Expenses | $40.40M | $28.02M | $22.33M | $23.12M | $21.65M | $30.69M | $33.80M | $27.38M |
| **Operating Income** | -$40.40M | -$28.02M | -$22.33M | -$23.12M | -$21.65M | -$30.69M | -$33.80M | -$27.38M |
| **EBITDA** | -$40.31M | -$27.95M | -$22.26M | -$23.04M | -$21.57M | -$30.63M | -$33.74M | -$27.31M |
| Interest Income | $2.16M | $2.19M | $2.11M | $2.21M | $1.46M | $1.27M | $1.19M | $1.47M |
| Interest Expense | $12K | $14K | $17K | $20K | $22K | $25K | $28K | $30K |
| Income Before Tax | -$38.30M | -$25.87M | -$20.20M | -$20.63M | -$20.28M | -$26.10M | -$32.66M | -$26.03M |
| **Net Income** | -$38.30M | -$25.87M | -$20.20M | -$20.96M | -$20.28M | -$26.10M | -$32.66M | -$25.92M |
| Basic EPS | -$0.43 | -$0.30 | -$0.25 | -- | -$0.33 | -$0.60 | -$0.99 | -- |
| **Diluted EPS** | -$0.43 | -$0.30 | -$0.25 | -- | -$0.33 | -$0.60 | -$0.99 | -- |
| Basic Shares Outstanding | 88.7M | 85.6M | 81.2M | -- | 61.0M | 43.6M | 33.1M | -- |
| Diluted Shares Outstanding | 88.7M | 85.6M | 81.2M | -- | 61.0M | 43.6M | 33.1M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $63.00M | $35.01M | $121.5M | $77.33M |
| Short-Term Investments | $118.8M | $86.50M | -- | -- |
| **Cash & Short-Term Investments** | $181.8M | $128.5M | $121.5M | $77.33M |
| Other Current Assets | -- | -- | $3.0K | $371K |
| **Total Current Assets** | $188.4M | $126.1M | $124.3M | $80.05M |
| Property, Plant & Equipment, Net | $1.14M | $1.03M | $1.06M | $998K |
| Long-Term Investments | $64.80M | $7.01M | -- | -- |
| **Total Non-Current Assets** | $80.30M | $20.82M | $15.51M | $17.03M |
| **Total Assets** | $268.7M | $146.9M | $139.8M | $97.08M |
| Accounts Payable | $4.86M | $6.42M | $3.79M | $2.68M |
| **Total Current Liabilities** | $16.81M | $22.85M | $17.24M | $14.35M |
| **Total Non-Current Liabilities** | $5.21M | $7.25M | $9.03M | $10.65M |
| **Total Liabilities** | $22.02M | $30.10M | $26.27M | $25.00M |
| **Total Debt (incl. Leases)** | $7.89M | $9.92M | $11.64M | $13.48M |
| Common Stock | $7.0K | $3.0K | $3.0K | $0 |
| Retained Earnings | -$380.1M | -$280.2M | -$181.8M | -$115.4M |
| Accumulated Other Comp. Income | $188K | -$103K | -- | -- |
| **Total Stockholders' Equity** | $246.7M | $116.8M | $113.5M | -$113.0M |
| Total Equity | $246.7M | $116.8M | $113.5M | -$113.0M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $90.22M | $92.83M | $71.77M | $63.00M | $41.00M | $35.48M | $28.91M | $35.01M |
| Short-Term Investments | $104.6M | $118.9M | $121.3M | $118.8M | $81.77M | $97.41M | $70.92M | $86.50M |
| **Cash & Short-Term Investments** | $219.1M | $234.2M | $227.6M | $181.8M | $122.8M | $132.9M | $106.9M | $128.5M |
| **Total Current Assets** | $204.9M | $217.9M | $200.9M | $188.4M | $127.8M | $140.1M | $105.3M | $126.1M |
| Property, Plant & Equipment, Net | $1.73M | $1.12M | $1.10M | $1.14M | $1.23M | $1.11M | $1.04M | $1.03M |
| Long-Term Investments | $24.35M | $22.47M | $34.51M | $64.80M | $0 | $19.61M | $7.04M | $7.01M |
| **Total Non-Current Assets** | $38.99M | $36.99M | $49.49M | $80.30M | $16.05M | $36.01M | $20.42M | $20.82M |
| **Total Assets** | $243.9M | $254.9M | $250.4M | $268.7M | $143.8M | $176.1M | $125.7M | $146.9M |
| Accounts Payable | $3.69M | $4.18M | $3.33M | $4.86M | $4.66M | $20.02M | $11.98M | $6.42M |
| **Total Current Liabilities** | $23.59M | $15.69M | $14.19M | $16.81M | $17.27M | $31.59M | $30.82M | $22.85M |
| **Total Non-Current Liabilities** | $3.64M | $4.14M | $4.67M | $5.21M | $5.74M | $6.26M | $6.75M | $7.25M |
| **Total Liabilities** | $27.23M | $19.84M | $18.86M | $22.02M | $23.01M | $37.85M | $37.58M | $30.10M |
| **Total Debt (incl. Leases)** | $6.25M | $6.81M | $7.37M | $7.89M | $8.46M | $8.91M | $9.40M | $9.92M |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K |
| Retained Earnings | -$464.5M | -$426.2M | -$400.3M | -$380.1M | -$359.2M | -$338.9M | -$312.8M | -$280.2M |
| Accumulated Other Comp. Income | -$465K | -$298K | -$142K | $188K | $89K | -$13K | -$54K | -$103K |
| **Total Stockholders' Equity** | $216.7M | $235.1M | $231.5M | $246.7M | $120.8M | $138.2M | $88.11M | $116.8M |
| Total Equity | $216.7M | $235.1M | $231.5M | $246.7M | $120.8M | $138.2M | $88.11M | $116.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$99.96M | -$98.33M | -$66.39M | -$59.28M |
| Depreciation & Amortization | $268K | $304K | $271K | $120K |
| Stock-Based Compensation | $12.13M | $12.47M | $3.04M | $1.78M |
| Change in Payables | -$1.56M | $2.38M | -$180K | -$426K |
| **Operating Cash Flow** | -$98.56M | -$81.15M | -$59.50M | -$54.56M |
| Capital Expenditure | -$397K | -$481K | -$115K | -$672K |
| **Free Cash Flow** | -$98.96M | -$81.63M | -$59.61M | -$55.23M |
| Purchases of Investments | -$195.4M | -$93.60M | -- | -- |
| Sales & Maturities of Investments | $105.5M | -- | -- | -- |
| **Investing Cash Flow** | -$90.25M | -$94.08M | -$165K | -$901K |
| Common Stock Issued | $270K | -- | -- | -- |
| **Financing Cash Flow** | $216.8M | $88.78M | $103.8M | $189K |
| **Net Change in Cash** | $27.98M | -$86.45M | $44.13M | -$55.27M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$38.30M | -$25.87M | -$20.20M | -$20.92M | -$20.28M | -$26.10M | -$32.66M | -$25.92M |
| Depreciation & Amortization | $86K | $74K | $73K | $73K | $73K | $62K | $60K | $75K |
| Stock-Based Compensation | $3.69M | $5.69M | $2.75M | $2.71M | $2.65M | $3.07M | $3.70M | $3.51M |
| Change in Payables | -$883K | $828K | -$1.60M | $200K | -$15.27M | $8.36M | $5.14M | -$2.04M |
| **Operating Cash Flow** | -$28.56M | -$17.60M | -$21.14M | -$20.08M | -$29.55M | -$27.22M | -$21.72M | -$28.33M |
| Capital Expenditure | -$298K | -$7.0K | -$35K | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -$28.86M | -$17.60M | -$21.18M | -- | -- | -- | -- | -$28.33M |
| Sales & Maturities of Investments | $32.20M | $26.24M | $27.50M | $38.33M | $35.30M | $16.30M | $15.60M | -- |
| **Investing Cash Flow** | $11.92M | $14.26M | $27.46M | -$101.7M | $35.01M | -$39.17M | $15.60M | -$93.58M |
| Common Stock Issued | $14.61M | $24.86M | $143K | $270K | $0 | -$170K | $170K | -- |
| **Financing Cash Flow** | $14.03M | $24.40M | $2.45M | $143.8M | $52K | $72.96M | $11K | -$97K |
| **Net Change in Cash** | -$2.62M | $21.07M | $8.77M | $22.00M | $5.52M | $6.57M | -$6.11M | -$122.0M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -9252.1% |
| **Net Profit Margin** | -- | -- | -- | -9063.8% |
| Return on Equity (ROE) | -40.5% | -84.2% | -58.5% | -- |
| Return on Assets (ROA) | -37.2% | -66.9% | -47.5% | -61.1% |
| Current Ratio | 11.21x | 5.52x | 7.21x | 5.58x |
| Quick Ratio | 10.81x | 5.62x | 7.05x | 5.39x |
| Debt to Equity | 0.03x | 0.08x | 0.10x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -48.6% | -37.1% | -37.8% | -40.5% | -86.9% | -82.6% | -124.1% | -84.2% |
| Return on Assets (ROA) | -43.2% | -34.3% | -35.0% | -37.2% | -73.0% | -64.8% | -87.0% | -66.9% |
| Current Ratio | 8.69x | 13.89x | 14.16x | 11.21x | 7.40x | 4.43x | 3.42x | 5.52x |
| Quick Ratio | 9.29x | 14.92x | 16.04x | 10.81x | 7.11x | 4.21x | 3.47x | 5.62x |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.03x | 0.07x | 0.06x | 0.11x | 0.08x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
